Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 1—January 2020
Research Letter

Influenza A Virus Infections in Dromedary Camels, Nigeria and Ethiopia, 2015–2017

Daniel K.W. Chu1, Ranawaka A.P.M. Perera1, Abraham Ali1, Jamiu O. Oladipo, Gezahegne Mamo, Ray T.Y. So, Ziqi Zhou, Yen Yeen Chor, Chak Kai Chan, Desalegn Belay, Adamu Tayachew, Mesfin Mengesha, Feyesa Regassa, Nga Ting Lam, Leo L.M. Poon, and Malik PeirisComments to Author 
Author affiliations: The University of Hong Kong, Hong Kong, China (D.K.W. Chu, R.A.P.M. Perera, J.O. Oladipo, R.T.Y. So, Z. Zhou, Y.Y. Chor, C.K. Chan, N.T. Lam, L.L.M. Poon, M. Peiris); Ethiopian Public Health Institute, Addis Ababa, Ethiopia (A. Ali, D. Belay, A. Tayachew, M. Mengesha, F. Regassa); Addis Ababa University, Bishoftu, Ethiopia (G. Mamo)

Cite This Article

Abstract

We examined nasal swabs and serum samples acquired from dromedary camels in Nigeria and Ethiopia during 2015–2017 for evidence of influenza virus infection. We detected antibodies against influenza A(H1N1) and A(H3N2) viruses and isolated an influenza A(H1N1)pdm09–like virus from a camel in Nigeria. Influenza surveillance in dromedary camels is needed.

Aquatic wild birds are the natural reservoir of influenza A virus, which comprises 16 hemagglutinin and 9 neuraminidase subtypes. Influenza A virus subtypes H1N1, H2N2, and H3N2 have caused pandemics in humans, and subtypes H1N1 and H3N2 circulate in humans as seasonal influenza. Pandemic influenza arises when an animal influenza virus evolves through the reassortment of animal and human virus gene segments (antigenic shift) to sustainably transmit in humans. Avian and swine influenza viruses have caused zoonotic infections, some resulting in fatal disease. Thus, influenza virus surveillance in animals is needed for pandemic preparedness (1).

Dromedary camel populations, estimated to be 30 million globally, can be found in parts of Africa, the Middle East, and Central Asia, often in close proximity to humans. An equine influenza A(H3N8) virus (2) and human influenza A/USSR/90/77(H1N1)–like viruses (which were associated with fatal disease in 1980–1983) (3) have been isolated from Bactrian camels in Mongolia. However, little is known of influenza A virus infections in dromedary populations. Therefore, we carried out a study to determine the prevalence of influenza A virus infection in dromedary camels.

As part of an investigation of Middle East respiratory syndrome coronavirus conducted during October 2015–February 2016 (4), we collected 2,166 nasal swabs and 150 serum samples from dromedaries at an abattoir in Kano, Nigeria. We also collected 102 nasal swabs and 100 serum samples from nomadic dromedary herds in Amibara, Ethiopia (in January 2017); 109 nasal swabs from herds in Asayita, Ethiopia (in July 2017); and 83 nasal swabs from herds in Dubti, Ethiopia (in July 2017). We put nasal swabs in virus transport medium, stored samples frozen at −80°C, and shipped them to Hong Kong, China, on dry ice for laboratory tests. We performed RNA extraction and detected the influenza A virus matrix gene using molecular methods (Appendix) (5).

Twelve nasal swabs from camels in Nigeria collected at different times (October [n = 5] and November [n = 5] 2015 and January [n = 1] and February [n = 1] of 2016) were positive for the influenza A virus matrix gene; cycle thresholds for these samples were 33.7–38.9 (Appendix Table). One of the nasal swabs collected in Amibara was also positive (cycle threshold 37.8). We inoculated quantitative reverse transcription PCR–positive samples onto Madin Darby canine kidney cells grown in 24-well plates in minimum essential medium with tosylsulfonyl phenylalanyl chloromethyl ketone–treated trypsin (2 µg/mL) (Appendix) (6). We examined inoculated cells for cytopathic effect and passaged each culture twice. We defined virus detection as the appearance of cytopathic effect or the hemagglutination of turkey erythrocytes. We were able to isolate 1 virus, which we designated A/dromedary/NV1337/2016 (H1N1), from a swab collected in Nigeria on January 22, 2016 (Appendix Table).

We performed full-genome sequencing of A/dromedary/NV1337/2016 (Appendix) as previously described (6). We achieved sequencing read coverages of >100 for each nucleotide and were able to deduce the full virus genome (GenBank accession nos. MN453859–66). All 8 gene segments showed their highest identity (>99.8) to contemporary influenza A(H1N1)pdm09 viruses (data not shown).

Figure

Thumbnail of Maximum-likelihood phylogenetic tree showing relationship of influenza A(H1N1)pdm09 virus from dromedary camel, Nigeria, January 2016 (red circle), relative to other influenza A(H1N1)pdm09 viruses from humans worldwide on the basis of the hemagglutinin gene. Tree was constructed by using a general time-reversible model with FastTree (https://www.geneious.com/plugins/fasttree-plugin) and PhyML (http://www.atgc-montpellier.fr/phyml) (Appendix,). Tree is rooted with an influenza A(H1N1

Figure. Maximum-likelihood phylogenetic tree showing relationship of influenza A(H1N1)pdm09 virus from dromedary camel, Nigeria, January 2016 (red circle), relative to other influenza A(H1N1)pdm09 viruses from humans worldwide on the basis of the...

In a phylogenetic analysis, we compared the hemagglutinin gene of A/dromedary/NV1337/2016 with that of other influenza A(H1N1)pdm09 viruses available from GenBank and GISAID (https://platform.gisaid.org) (Figure). The dromedary influenza A virus isolated in Nigeria in January 2016 was similar to other influenza viruses circulating in humans at the same time. The sampling dates for the influenza viruses detected in camels in Nigeria overlapped with the human influenza virus season, which typically occurs during October–March (Appendix Table) (7). This finding suggests reverse zoonosis of influenza viruses from humans to dromedaries. Whether these viruses were subsequently maintained in dromedary populations via camel-to-camel transmission is not clear. Further studies are needed to address this question. Transmission of influenza A virus also occurs from humans to swine, and these viruses can be maintained in swine populations for variable periods, sometimes decades (8).

We tested serum samples from dromedary camels for hemagglutination inhibition (HI) antibody against A/dromedary/NV1337/2016(H1N1) using standard methods (Appendix) (5); 4 serum samples from camels in Amibara had HI antibody (titers 1:40, 1:80, 1:160, and 1:160). The dromedaries that had influenza A virus RNA–positive nasal swabs were negative for HI antibody. Dromedaries recently infected with a virus are expected to be seronegative for that virus because antibody responses against viruses take around a week to develop (9), by which time nasal swab specimens are often negative for that virus’s genomic material. Microneutralization tests are more appropriate for testing antibody to contemporary H3N2 viruses (10); hence, we also tested serum samples for antibody to A/Hong Kong/4801/2014(H3N2) virus using the microneutralization test (Appendix). In total, 1 serum sample from a camel in Nigeria was positive at a titer of 1:80.

In conclusion, we provide evidence of influenza A virus infection in dromedaries. Our findings indicate that influenza virus surveillance in dromedary camel populations is needed.

Dr. Chu is a research assistant professor at The University of Hong Kong, Hong Kong. His research focuses on influenza and coronaviruses of humans and animals and his interests focus on diagnostic virology, molecular diagnostics, and virus evolution.

Top

Acknowledgment

This research was funded by the Theme Based Research Scheme (reference no. T11-705/14N) from the Research Grants Council of the Hong Kong Special Administrative Region, China, and from the US National Institute of Allergy and Infectious Diseases under Centers of Excellence for Influenza Research and Surveillance contract no. HHSN272201400006C.

Top

References

  1. Webster  RG, Bean  WJ, Gorman  OT, Chambers  TM, Kawaoka  Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56:15279.PubMed
  2. Yondon  M, Zayat  B, Nelson  MI, Heil  GL, Anderson  BD, Lin  X, et al. Equine influenza A(H3N8) virus isolated from Bactrian camel, Mongolia. Emerg Infect Dis. 2014;20:21447. DOIPubMed
  3. Yamnikova  SS, Mandler  J, Bekh-Ochir  ZH, Dachtzeren  P, Ludwig  S, Lvov  DK, et al. A reassortant H1N1 influenza A virus caused fatal epizootics among camels in Mongolia. Virology. 1993;197:55863. DOIPubMed
  4. So  RT, Perera  RA, Oladipo  JO, Chu  DK, Kuranga  SA, Chan  KH, et al. Lack of serological evidence of Middle East respiratory syndrome coronavirus infection in virus exposed camel abattoir workers in Nigeria, 2016. Euro Surveill. 2018;23. DOIPubMed
  5. Duchamp  MB, Casalegno  JS, Gillet  Y, Frobert  E, Bernard  E, Escuret  V, et al. Pandemic A(H1N1)2009 influenza virus detection by real time RT-PCR: is viral quantification useful? Clin Microbiol Infect. 2010;16:31721. DOIPubMed
  6. Baudon  E, Chu  DKW, Tung  DD, Thi Nga  P, Vu Mai Phuong  H, Le Khanh Hang  N, et al. Swine influenza viruses in Northern Vietnam in 2013-2014. Emerg Microbes Infect. 2018;7:123. DOIPubMed
  7. Newman  LP, Bhat  N, Fleming  JA, Neuzil  KM. Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016. PLoS One. 2018;13:e0193263. DOIPubMed
  8. Shortridge  KF, Webster  RG, Butterfield  WK, Campbell  CH. Persistence of Hong Kong influenza virus variants in pigs. Science. 1977;196:14545. DOIPubMed
  9. Abdellatif  MM, Ibrahim  AA, Khalafalla  AI. Development and evaluation of a live attenuated camelpox vaccine from a local field isolate of the virus. Rev Sci Tech. 2014;33:8318. DOIPubMed
  10. Laurie  KL, Engelhardt  OG, Wood  J, Heath  A, Katz  JM, Peiris  M, et al.; CONSISE Laboratory Working Group participants. International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE. Clin Vaccine Immunol. 2015;22:95764. DOIPubMed

Top

Figure

Top

Cite This Article

DOI: 10.3201/eid2601.191165

Original Publication Date: 12/10/2019

1These authors contributed equally to this article.

Table of Contents – Volume 26, Number 1—January 2020

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Malik Peiris, The University of Hong Kong School of Public Health, No. 7 Sassoon Rd, Pokfulam, Hong Kong

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: December 18, 2019
Page updated: December 18, 2019
Page reviewed: December 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external